medvi glp1

Last updated: June 23, 2026

Quick Answer: MEDVi GLP-1 is a physician-led telehealth weight-loss program that provides compounded semaglutide and tirzepatide to eligible patients across the United States. As of 2026, the platform reports serving over 100,000 patients, offering supervised injectable GLP-1 therapy at significantly lower costs than brand-name alternatives like Ozempic or Wegovy. It is best suited for adults with a BMI of 27 or higher who want structured, medically supervised weight loss without navigating traditional insurance barriers. [4]

---

Our Verdict: 4.8 / 5 – Highly Recommended

Our Top GLP-1 Providers

Table of Contents - [Open] ➨

Toggle

7 Best GLP-1 Providers Ranked: Accreditation, Flexibility & Support Compared (2026 Update)

32,000+ Patients Can't All Be Wrong: See the Top-Rated GLP-1 Providers. We compared the leading online GLP-1 providers based on program features, clinical support, convenience, and overall value.

✓ Quick comparison: See which provider best fits your needs.

★ Our Top Pick

1

BMI MD

BMI MD GLP-1 Microdosing Plan

Best for: Microdosing & maintenance

• Specialized microdosing options, including sublingual drops and low-dose injections
• Designed for people interested in maintaining weight or gradually adjusting treatment
• Bundled program structure without a separate monthly platform membership
• Online access makes the process convenient from home

4.9

★★★★★

32,200+ Reviews

Check BMI MD

See current program options

2

DirectMEDs

DirectMeds Weight Loss Solutions

Best for: Straightforward online access

• Online weight-loss program with a straightforward patient experience
• Compounded medication options through state-licensed compounding pharmacies
• Includes clinical consultation as part of the process
• Provides shipping updates to help patients track their orders

4.8

★★★★★

2,100+ Reviews

Explore DirectMEDs

View current program details

3

MEDVi

MEDVi Flat-Rate Telehealth

Best for: Predictable program structure

• Flat-rate telehealth approach designed for easier budgeting
• No dosage-based pricing increases within the advertised program structure
• Offers injectable and oral thin-film delivery options
• Includes medical screening and asynchronous provider consultations

4.6

★★★★☆

1,800+ Reviews

Explore MEDVi

See current treatment options

4

ShedRx GLP-1

Gala GLP-1 Care Program

Best for: Ongoing clinician messaging

• Text-based access to state-licensed clinicians
• Cold-chain medication shipping included in the program
• Month-to-month program structure
• Designed for people who value convenient ongoing support

4.5

★★★★☆

1,400+ Reviews

Start Assessment

See if the program fits

5

Measured

Measured GLP-1 Metabolic Health

Best for: Metabolic health tracking

• Comprehensive metabolic health screening and intake analysis
• Designed around longer-term metabolic health management
• Responsive dashboard with integrated health tracking tools
• Useful option for patients who value a more data-focused experience

4.3

★★★★☆

900+ Reviews

Explore Measured

Review the complete program

6

Gala GLP-1

Refills GLP-1 (TryRefills Plan)

Best for: Side-effect support

• Clinical guidance designed to help patients manage common treatment concerns
• Includes foundational nutritional strategies alongside medication
• Designed around predictable ongoing treatment
• No hidden startup or processing fees according to the program information provided

4.2

★★★★☆

450+ Reviews

Explore Refills

View current program details

7

Refills GLP-1

AltRx GLP-1 Transactional Reorders

Best for: Experienced patients

• Transactional reorder model without recurring auto-billing
• Designed for patients who already understand their treatment routine
• Fast text-to-order process for convenient reorders
• Offers injectable and fast-dissolving tablet variations

4.1

★★★★☆

280+ Reviews

Explore Refills

See current options

Important: GLP-1 medications require medical evaluation and may not be appropriate for everyone. Program availability, eligibility, medication options, and terms can change. Review the provider's current information and consult a qualified healthcare professional before starting treatment.

Best for: Adults with BMI 27+ seeking affordable compounded semaglutide or tirzepatide
Best for: Busy individuals who prefer telehealth over in-person clinic visits
Best for: People without insurance coverage for GLP-1 medications
Skip if: You are pregnant, breastfeeding, or have a personal or family history of medullary thyroid carcinoma
Skip if: You are looking for an over-the-counter supplement with no medical oversight

Check Lowest Price on MEDVi Official Site

---

Key Takeaways

• MEDVi Semaglutide is a compounded GLP-1 medication dispensed through a licensed telehealth platform with physician oversight at every step.
• The program has served more than 100,000 patients as of early 2026, with an updated intake and dosing protocol. [4]
• Compounded semaglutide through MEDVi costs significantly less per month than brand-name Wegovy or Ozempic, making it one of the most affordable GLP-1 options available without insurance.
• MEDVi also offers a physician-led program to help patients choose between semaglutide and tirzepatide based on their health profile. [10]
• Patients start with a low dose that increases gradually, which helps minimize common GLP-1 side effects like nausea.
• The platform ships medication directly to your door after an online consultation and prescription approval.
• MEDVi is not a supplement brand. It is a regulated telehealth medical service using FDA-registered compounding pharmacies.
• Clinical data on GLP-1 receptor agonists shows meaningful weight loss results, with some trials reporting 10 to 15 percent body weight reduction over 68 weeks. [5]

---

What Is MEDVi GLP-1 and How Does the Program Work?

MEDVi is a telehealth platform that connects patients with licensed physicians who prescribe compounded GLP-1 medications, primarily semaglutide and tirzepatide. The program is fully online: you complete a health intake form, consult with a provider, and receive medication shipped to your home if approved. [7]

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals the brain to reduce appetite, slows stomach emptying, and helps regulate blood sugar. Injectable GLP-1 receptor agonists like semaglutide mimic this hormone at much higher concentrations than your body produces naturally, which is why they produce meaningful, sustained weight loss. [5]

MEDVi’s compounded semaglutide uses the same active molecule as Wegovy and Ozempic but is prepared by FDA-registered compounding pharmacies. This is what keeps the cost lower than the brand-name versions. [2]

How the program works, step by step:

1. Complete an online health questionnaire (takes about 10 minutes).
2. A licensed physician reviews your information and medical history.
3. If approved, you receive a prescription and your medication is shipped directly to you.
4. You follow a gradual dose escalation protocol (starting low, increasing monthly).
5. Ongoing provider check-ins are available through the platform.

Ready to start? Claim Your MEDVi GLP-1 Consultation Today and get access to physician-supervised weight loss from home.

---

Is MEDVi GLP-1 Legit? Safety, Regulation, and What to Expect

MEDVi GLP-1 is a legitimate, physician-supervised telehealth service. It is not a supplement sold over the counter. Medications are dispensed through compounding pharmacies that operate under FDA oversight, and every prescription requires approval from a licensed U.S. physician. [9]

Safety profile of compounded semaglutide:

• The active ingredient, semaglutide, has been studied extensively in clinical trials. The STEP trial series, for example, demonstrated significant weight loss outcomes in adults with obesity or overweight. [5]
• Common side effects include nausea, constipation, and mild fatigue, especially in the first few weeks. These typically improve as the body adjusts.
• Serious but rare risks include pancreatitis and, based on animal studies, a potential thyroid tumor risk. This is why people with a history of medullary thyroid carcinoma or MEN2 syndrome should not use GLP-1 medications.

Who should NOT use MEDVi GLP-1:

• Pregnant or breastfeeding individuals
• Anyone with a personal or family history of medullary thyroid carcinoma
• People with a history of pancreatitis (consult your doctor first)
• Those currently taking other GLP-1 medications

For a broader look at how to safely purchase GLP-1 medications online, see our GLP-1 buy online safety guide.

---

MEDVi GLP-1 Pricing: How Much Does It Cost in 2026?

MEDVi GLP-1 is one of the most affordable compounded semaglutide programs available in 2026. Pricing varies based on medication type (semaglutide vs. tirzepatide) and dosage tier, but compounded versions consistently undercut brand-name alternatives by a wide margin.

Estimated monthly cost comparison (2026):

Medication	MEDVi (Compounded)	Brand Name (Retail)
Semaglutide	~$199 – $299/month	~$900 – $1,400/month
Tirzepatide	~$299 – $399/month	~$1,000 – $1,500/month

Note: Brand-name prices are estimates based on average U.S. retail pharmacy pricing without insurance. MEDVi pricing is subject to change. Always verify current pricing on the official site.

The cost difference is substantial. For patients without insurance coverage, compounded semaglutide through MEDVi can save hundreds of dollars per month compared to Wegovy or Ozempic. For a full breakdown of what GLP-1 medications cost without insurance, see our cost of GLP-1 without insurance guide.

See Current MEDVi Pricing and Start Your Program – No insurance required.

---

MEDVi GLP-1 vs. Competitors: How Does It Compare?

MEDVi GLP-1 competes directly with other telehealth GLP-1 platforms. Here is how it stacks up against two major alternatives.

Feature	MEDVi	Hims/Hers	Ro Body
Medication type	Semaglutide + Tirzepatide	Semaglutide	Semaglutide
Physician oversight	Yes	Yes	Yes
Estimated monthly cost	~$199 – $399	~$299 – $399	~$299+
Patient count (2026)	100,000+ [4]	Not disclosed	Not disclosed
Tirzepatide option	Yes [10]	Limited	No
Money-back policy	Varies by plan	Varies	Varies

MEDVi’s key advantage is its physician-led semaglutide vs. tirzepatide selection program, which helps patients choose the right medication based on their metabolic profile rather than defaulting to one option. [10] This is a meaningful differentiator for patients who want personalized guidance.

You can also compare options in our Hims semaglutide review and our Ro Body review for side-by-side context.

Try MEDVi GLP-1 Today – The Smarter, More Affordable Choice

---

Real Results: What Can You Expect from MEDVi GLP-1?

Clinical evidence on GLP-1 receptor agonists is strong. Semaglutide trials have shown average body weight reductions of 10 to 15 percent over approximately 68 weeks in adults with obesity. [5] Tirzepatide trials have shown even higher averages in some populations.

What a realistic 30-day experience with MEDVi GLP-1 looks like:

• Week 1: Reduced appetite, possible mild nausea at the starting dose. Most users report feeling full faster at meals.
• Week 2: Nausea typically decreases. Calorie intake drops naturally without strict dieting.
• Weeks 3 to 4: Noticeable scale movement for most users. Energy levels stabilize. Cravings for high-calorie foods decrease.

Reported pros from patient experience data:

• Significant reduction in hunger and food cravings
• Gradual, sustainable weight loss without crash dieting
• Convenient home delivery with no pharmacy visits
• Physician support available throughout the program
• Option to switch between semaglutide and tirzepatide if needed

Reported cons:

• Nausea in the first 1 to 2 weeks is common
• Results require patience; rapid loss is not typical in week one
• Not covered by most insurance plans when obtained through compounding

For context on how compounded semaglutide compares to brand-name options, see our compounded vs. brand semaglutide guide.

---

Semaglutide vs. Tirzepatide: Which MEDVi GLP-1 Option Should You Choose?

MEDVi launched a physician-led program specifically to help patients navigate the semaglutide vs. tirzepatide decision, which is one of the most common questions new patients ask. [10]

Choose semaglutide if:

• You are new to GLP-1 therapy and want to start with the most studied option
• You are more sensitive to side effects and prefer a gentler dose escalation
• Cost is the primary concern (semaglutide is generally less expensive)

Choose tirzepatide if:

• You have already tried semaglutide with limited results
• Your provider recommends a dual GIP/GLP-1 agonist based on your metabolic profile
• You are comfortable with a slightly higher monthly cost for potentially stronger appetite suppression

For a detailed breakdown of the differences, read our semaglutide vs. tirzepatide comparison.

Talk to a MEDVi Physician Today and Find Out Which GLP-1 Is Right for You

---

Is MEDVi GLP-1 Worth It? The Final Verdict

MEDVi GLP-1 delivers on its core promise: affordable, physician-supervised access to compounded semaglutide and tirzepatide for adults who qualify. The platform’s scale (100,000+ patients as of 2026) [4], its structured dose escalation protocol, and its physician-led medication selection program set it apart from generic telehealth competitors.

For adults with a BMI of 27 or higher who do not have insurance coverage for GLP-1 medications, MEDVi is one of the most cost-effective and medically credible options available. It is not a supplement. It is not a shortcut. It is a structured medical program that uses clinically validated medications at a price point that makes long-term use realistic.

The bottom line: If you have been priced out of Wegovy or Ozempic, or if you want a telehealth program with genuine physician oversight and the option to choose between semaglutide and tirzepatide, MEDVi Semaglutide is worth serious consideration in 2026.

Yes, I Want to Lose Weight with MEDVi GLP-1 – Start My Program Now

---

Conclusion

More than 100 million American adults live with obesity, yet the most effective prescription tools for weight loss remain out of reach for many due to cost. MEDVi GLP-1 addresses this gap directly by offering compounded semaglutide and tirzepatide through a physician-supervised telehealth model at a fraction of the brand-name price. [4][2]

The science behind GLP-1 receptor agonists is not in question. The clinical evidence is substantial. What MEDVi adds is access: a structured program, licensed medical oversight, and direct-to-door delivery that removes the friction most patients face when trying to start treatment.

Your next steps:

1. Visit the MEDVi GLP-1 official program page and complete the free health intake form.
2. Review the semaglutide vs. tirzepatide options with your assigned physician.
3. If approved, begin your dose escalation protocol and track your progress monthly.
4. Use the platform’s check-in tools to adjust dosing as needed under physician guidance.

If you want to compare other affordable options before deciding, see our list of the most affordable weight loss injections in 2026 and our best GLP-1 options under $300.

Do Not Wait – Stock Is Limited. Start Your MEDVi GLP-1 Program Today

---

Frequently Asked Questions

Does MEDVi GLP-1 actually work for weight loss?

Yes, based on clinical evidence for semaglutide and tirzepatide, the active medications in MEDVi’s program produce meaningful weight loss in eligible adults. Trials have shown average reductions of 10 to 15 percent of body weight over 68 weeks with semaglutide. [5] Individual results vary based on adherence, diet, and starting weight.

Is MEDVi GLP-1 FDA approved?

The active ingredient, semaglutide, is FDA approved in its brand-name forms (Wegovy, Ozempic). MEDVi uses compounded semaglutide, which is prepared by FDA-registered compounding pharmacies. Compounded medications are legal and regulated but are not individually FDA approved as finished drug products. [9]

How much does MEDVi GLP-1 cost per month?

Estimated pricing in 2026 ranges from approximately $199 to $299 per month for compounded semaglutide and $299 to $399 for tirzepatide. This is significantly less than brand-name alternatives. Always verify current pricing directly on the MEDVi site, as costs may change.

Can I get MEDVi GLP-1 without insurance?

Yes. MEDVi is specifically designed for patients who do not have insurance coverage for GLP-1 medications. No insurance is required to enroll or receive medication.

What are the side effects of MEDVi semaglutide?

The most common side effects are nausea, constipation, and mild fatigue, especially during the first two to four weeks. These typically improve as your dose stabilizes. Serious side effects are rare but include pancreatitis and potential thyroid concerns. Discuss your full medical history with your MEDVi physician before starting.

How long does it take to see results with MEDVi GLP-1?

Most patients notice reduced appetite within the first week. Visible weight loss typically begins by weeks two to four. Significant results (5 to 10 percent body weight reduction) are generally seen over three to six months of consistent use.

Is MEDVi GLP-1 the same as Ozempic or Wegovy?

MEDVi uses compounded semaglutide, which contains the same active molecule as Ozempic and Wegovy but is produced by a compounding pharmacy rather than Novo Nordisk. The pharmacological mechanism is identical, but the product is not the same as the FDA-approved branded drug.

Who qualifies for MEDVi GLP-1?

Generally, adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition (such as type 2 diabetes or hypertension), may qualify. A licensed MEDVi physician makes the final determination after reviewing your health intake form.

Does MEDVi offer tirzepatide as well as semaglutide?

Yes. MEDVi offers both compounded semaglutide and tirzepatide. The platform includes a physician-led program to help patients choose the right option based on their individual health profile. [10]

What happens if MEDVi GLP-1 does not work for me?

MEDVi’s physician team can adjust your dosage or switch you between semaglutide and tirzepatide if your initial medication is not producing adequate results. Contact the platform’s medical team directly to discuss your options.

---

References

[1] Medvi GLP-1 Weight Loss – https://finance.yahoo.com/news/medvi-glp-1-weight-loss-230300605.html

[2] Medvi Expands Access to GLP-1 Medication Compounded Semaglutide for Healthy Living – https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/33754016/medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living/

[3] Oral GLP-1 Tablets Gain – https://finance.yahoo.com/news/oral-glp-1-tablets-gain-193000392.html

[4] MEDVi Expands Access to Semaglutide Online With Updated Program Trusted by 100,000 Patients – https://business.bigspringherald.com/bigspringherald/article/abnewswire-2026-1-8-medvi-expands-access-to-semaglutide-online-with-updated-program-trusted-by-100000-patients

[5] Best Semaglutide for Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program – https://www.globenewswire.com/news-release/2025/12/27/3210709/0/en/Best-Semaglutide-For-Weight-Loss-2026-Is-MEDVi-the-Best-GLP-1-Supplier-for-a-Sustainable-Online-Weight-Loss-Program.html

[6] GLP-1 Pipeline Update May 2026 – https://www.primetherapeutics.com/glp-1-pipeline-update-may-2026

[7] MEDVi Official Site – https://home.medvi.org

[8] MEDVi Best GLP-1 Supplier – https://finance.yahoo.com/news/medvi-best-glp-1-supplier-041300519.html

[9] MEDVi and the Compounded GLP-1 Market in 2026 – https://utcardiothoracicsurgery.com/medvi-and-the-compounded-glp-1-market-in-2026/

[10] Semaglutide vs. Tirzepatide: MEDVi Launches Physician-Led Program to Help Patients Choose the Right GLP-1 – https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/37046469/semaglutide-vs-tirzepatide-medvi-launches-physicianled-program-to-help-patients-choose-the-right-glp1

---

Tags: medvi glp1, compounded semaglutide, GLP-1 weight loss, telehealth weight loss, semaglutide review, tirzepatide, affordable GLP-1, weight loss injections, MEDVi review, semaglutide vs tirzepatide, GLP-1 medications, online weight loss program